Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that neural stem/precursor cells (NPCs) promote recovery in animal models with delayed neuronal death via a number of indirect bystander effects. A comprehensive knowledge of how transplanted NPCs exert their therapeutic effects is still lacking. Here, we investigated the effects of a delayed transplantation of adult syngenic NPCs--injected intravenously 72 h after transient middle cerebral artery occlusion--on neurological recovery, histopathology and gene expression. NPC-transplanted mice showed a significantly improved recovery from 18 days post-transplantation (dpt) onwards, which persisted throughout the study. A small percentage of injected NPCs accumulated in the brain, integrating mainly in the infarct boundary zone, where most of the NPCs remained undifferentiated up to 30 dpt. Histopathological analysis revealed a hitherto unreported very delayed neuroprotective effect of NPCs, becoming evident at 10 and 30 dpt. Tissue survival was associated with downregulation of markers of inflammation, glial scar formation and neuronal apoptotic death at both mRNA and protein levels. Our data highlight the relevance of very delayed degenerative processes in the stroke brain that are intimately associated with inflammatory and glial responses. These processes may efficaciously be antagonized by (stem) cell-based strategies at time-points far beyond established therapeutic windows for pharmacological neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, beneficial effects were reported even when treatments were initiated days, weeks, or months after stroke.14–20”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“In addition to the sprouting of pyramidal tract fibres, remodelling of transcallosal projections connecting the two motor cortices occurs.14,25”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“By contrast with neuroprotection, which requires an acute intervention, treatments promoting neurological recovery by remodelling of brain tissue can be instituted during the stroke recovery phase.10–15”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“Microvessels and neuroblasts mutually support each other via release of trophic factors, resulting in a tight interplay that stimulates brain remodelling processes, reducing delayed neuronal degeneration,14,45 promoting neuronal plasticity,15 modulating glial responses,14,46 and attenuating brain inflammation14,46 (figure 2).”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“The finding that neural precursor cells prevent ischaemic injury and promote neurological recovery could be attributed to bystander effects related to the interaction of neuroblasts with the microvasculature in the vicinity of the ischaemic lesion, which creates an environment that promotes brain remodelling (figure 2).14,15,37,45”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 2×
“This might imply that therapies favouring endogenous tissue repair and/or remodelling may have realistic chances of success also when applied beyond established time-windows of tissue protection, which in the case of thrombolytics in humans are in the range of 3–6 h (Hacke et al., 2008).”
BackgroundPathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · cited 1×
“In the ischaemic border zone surrounding the evolving infarct, inflammatory responses and apoptotic programs are activated in this phase that further contribute to injury development (Dirnagl et al., 1999; Hermann et al., 2001; Hossmann, 2006).”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 2×
“Forty-five minutes of MCAO were induced in adult male 8- to 10-week old (weight 20–25 g) C57Bl/6 mice (Harlan Nossan, Netherlands), as previously described (Hata et al., 2000; Hermann et al., 2001).”
MethodInfluentialSelf-citationThe glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 2×
“Following the acute stroke phase, the tissue undergoes substantial matrix remodelling that results in (astro)glial scar formation, which is widely regarded as a major hampering factor for tissue repair and regeneration (Fawcett and Asher, 1999; Nedergaard and Dirnagl, 2005; Yiu and He, 2006).”
BackgroundInfluentialGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495 · cited 2×
“Gliotic scar formation is regarded as a major factor hampering recovery from stroke (Li et al., 2005; Yiu and He, 2006).”
BackgroundInfluentialRegulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115 · cited 1×
“Further, the importance of both TNF- and IFN-g is emphasized by the demonstration that antagonization of the production of either of these inflammatory cytokines significantly prevented secondary infarct growth after stroke (Liesz et al., 2009).”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 3×
“Key functions such as the replacement of neural cells (Pluchino et al., 2003; Karimi-Abdolrezaee et al., 2006) and the delivery of therapeutic gene(s) (Lee et al., 2007) have been recently challenged by intrinsic bystander capacities, mainly exerted by undifferentiated NPCs, releasing at the site…”
BackgroundMethodInfluentialSelf-citationInterleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 2×
“(Barone et al., 1997; Hallenbeck, 2002; Allan et al., 2005) that contribute to the detrimental post-ischaemic brain inflammation in”
BackgroundCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968 · cited 2×
“…rather than immune-suppressive action exerted by NPCs may be of pivotal interest as stroke is accompanied by an early peripheral immunodeficiency phase (Meisel et al., 2005; Offner et al., 2006; Offner et al., 2009) that limits the application of systemic immunosuppressive therapies.”
BackgroundActivation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 893 · cited 3×
“That the therapeutic window is so narrow has been explained by the fact that brain infarct evolves very rapidly, typically within a few hours up to 3–4 days after stroke, depending on the duration and severity of ischaemia (Garcia et al., 1993; Namura et al., 1998; Hata et al., 2000; Li et al., 2000; Hermann et al., 2…”
BackgroundInfluential
Cited by
Items 101–200 of 350
Herz, J., Reitmeir, R., Hagen, S. I., Reinboth, B. S., Guo, Z., Zechariah, A., ElAli, A., Doeppner, T. R., Bacigaluppi, M., Pluchino, S., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.026 · Cited by 62
“…markers 20 μm cryostat sections taken from the level of the bregma of mice that were transcardially perfused with 0.9% NaCl were used for immunohistochemistries using published fluorescence and avidin– peroxidase protocols (Bacigaluppi et al., 2009; Kilic et al., 2008; Reitmeir et al., 2011a).”
InfluentialSelf-citationNodari, L. R., Ferrari, D., Giani, F., Bossi, M., Rodriguez‐Menendez, V., Tredici, G., Delia, D., Vescovi, A. L., & Filippis, L. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014035 · Cited by 61
Tambalo, S., Peruzzotti‐Jametti, L., Rigolio, R., Fiorini, S., Bontempi, P., Mallucci, G., Balzarotti, B., Marmiroli, P., Sbarbati, A., Cavaletti, G., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0540-15.2015 · Cited by 59
Neural Stem Cells for Early Ischemic Stroke
Hamblin, M. H., & Lee, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147703 · Cited by 65
“NSC delivery in the early stroke phase attenuates this complex inflammatory signaling cascade [223,252,253] (Figure 2).”
BackgroundInfluentialPiemonte, F., Rossi, F., & Carletti, B. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596603 · Cited by 64
Effects of normobaric oxygen and melatonin on reperfusion injury: role of cerebral microcirculation
Beker, M. Ç., Çağlayan, A. B., Keleştemur, T., Çağlayan, B., Yalçın, E., Yuluğ, B., Kılıç, Ü., Hermann, D. M., & Kılıç, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5773 · Cited by 60
“disseminate neuronal injury in the striatum assessed by terminal transferase dUTP nick end labeling (TUNEL) in mice submitted to 30 min of intraluminal middle cerebral artery occlusion (MCAo), which induces disseminate neuronal injury in the striatum [3, 21].”
BackgroundMethodSelf-citationNeurogenic and non-neurogenic functions of endogenous neural stem cells
Butti, E., Cusimano, M., Bacigaluppi, M., & Martino, G. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00092 · Cited by 61
“In the post-acute phase of ischemic or haemorrhagic stroke, i.v. transplantation of NPCs reduced activation of macrophage/microglia cells and CNS recruitment of blood-borne inflammatory cells (Lee et al., 2008; Bacigaluppi et al., 2009).”
BackgroundSelf-citationPost-stroke Neurogenesis: Friend or Foe?
Cuartero, M. I., García‐Culebras, A., Torres‐López, C., Medina, V., Fraga, E., Vázquez‐Reyes, S., Jareño-Flores, T., García-Segura, J. M., Lizasoaín, I., & Moro, M. Á. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657846 · Cited by 72
Neural stem cell therapy for brain disease
Zhao, L., Liu, J.-W., Shi, H., & Ma, Y. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1278 · Cited by 65
Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell
Sarmah, D., Kaur, H., Saraf, J., Pravalika, K., Goswami, A., Kalia, K., Borah, A., Wang, X., Dave, K. R., Yavagal, D. R., et al. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0580-0 · Cited by 58
Exogenous neural stem cell transplantation for cerebral ischemia
Liao, L.-Y., Lau, B. W.-M., Sánchez-Vidaña, D. I., & Gao, Q. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.251188 · Cited by 58
Wang, Y., Dzyubenko, E., Sánchez-Mendoza, E. H., Sardari, M., de Carvalho, T. S., Doeppner, T. R., Kaltwasser, B., Machado, P., Kleinschnitz, C., Bassetti, C. L., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.021378 · Cited by 58
Self-citationThe central role of peripheral inflammation in ischemic stroke
Monsour, M., & Borlongan, C. V. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221149509 · Cited by 66
“Stem cell treatments in murine models of MCAO show reduced levels of pro-inflammatory cytokines TNF-a, IL-1b, and IFN-g gene transcription and increased transcription of the anti-inflammatory cytokine, IL-10.(119,120) A vital role of stem cells in modulating stroke damage involves their role in restoring NVU impermeab…”
BackgroundSUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke
Bernstock, J. D., Peruzzotti‐Jametti, L., Leonardi, T., Vicario, N., Ye, D. G., Lee, Y.-J., Maric, D., Johnson, K. R., Mou, Y., van den Bosch, A. M. R., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.035 · Cited by 59
“Compelling evidence exists that the transplantation of neural stem cells (NSCs) exerts bene fi cial effects in multiple CNS disorders, includ-ingstroke, through both thestructuralreplacementof endogenous neural cells as well as immunomodulatory and tissue trophic effects [2 – 4].”
Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage
Roll, L., & Faissner, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00219 · Cited by 55
“Systemically transplanted NSCs improved recovery in a stroke model and reduced the expression of inflammation-associated genes (Bacigaluppi et al., 2009).”
BackgroundNeural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System
Ottoboni, L., Merlini, A., & Martino, G. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00052 · Cited by 58
“…et al., 2011; Hassani et al., 2012; Mine et al., 2013), increase endogenous angiogenesis after stroke (Jiang et al., 2005), scavenge the neurotoxic molecules (Emsley et al., 2004) and contribute both directly and indirectly (via astrocytes) to glutamate clearance (Bacigaluppi et al., 2009, 2016).”
BackgroundSelf-citationOh, S.-H., Choi, C., Chang, D.-J., Shin, D. A., Lee, N., Jeon, I., Sung, J.-H., Lee, H., Hong, K.-S., Ko, J. J., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.04.007 · Cited by 56
Reekmans, K., Praet, J., Vocht, N. D., Tambuyzer, B. R., Bergwerf, I., Daans, J., Baekelandt, V., Vanhoutte, G., Goossens, H., Jorens, P. G., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x543411 · Cited by 53
“likely be performed using well-characterized (and possiease, stroke, and EAE (2,16,20,37,57), although the pre-”
BackgroundDe Feo, D., Merlini, A., Brambilla, E., Ottoboni, L., Laterza, C., Menon, R., Srinivasan, S., Farina, C., Garcia Manteiga, J. M., Butti, E., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92387 · Cited by 52
Self-citationDoeppner, T. R., Kaltwasser, B., Schlechter, J., Jaschke, J., Kılıç, E., Bähr, M., Hermann, D. M., & Weise, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.365 · Cited by 53
Self-citationLi, S.-H., Gao, P., Wang, L.-T., Yan, Y.-H., Xia, Y., Song, J., Li, H.-Y., & Yang, J.-X. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00340 · Cited by 46
“NSCs are a specific type of multipotent stem cells that are present in the hippocampus and subventricular zone (SVZ) of the brain (Bacigaluppi et al., 2009).”
BackgroundWu, S. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000142 · Cited by 56
“Indeed, aNSCs have been shown to be effective, not only in EAE, but in animal models of other types of neurodegenerative diseases [4–7].”
BackgroundDoeppner, T. R., Kaltwasser, B., Teli, M. K., Bretschneider, E., Bähr, M., & Hermann, D. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.359 · Cited by 54
“Mechanisms underlying post-ischemic neuroprotection after acute stem cell transplantation imply a variety of different events, among which stabilization of the BBB and reduction in post-ischemic inflammatory responses are most critically involved.(4,7,11) As such, modulation of both central and peripheral inflammatory…”
BackgroundSelf-citationHerz, J., Hagen, S. I., Bergmüller, E., Sabellek, P., Göthert, J. R., Buer, J., Hansen, W., Hermann, D. M., & Doeppner, T. R. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.022 · Cited by 57
Self-citationPurification of Immature Neuronal Cells from Neural Stem Cell Progeny
Azari, H., Osborne, G. W., Yasuda, T., Golmohammadi, M. G., Rahman, M., Deleyrolle, L. P., Esfandiari, E., Adams, D. J., Scheffler, B., Steindler, D. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020941 · Cited by 50
Wang, Y., Sánchez-Mendoza, E. H., Doeppner, T. R., & Hermann, D. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16648971 · Cited by 59
“furthermore analyzed by determining the tissue area covered by the corpus callosum.(17,20)”
BackgroundMethodSelf-citationSingle-cell sorting based on secreted products for functionally defined cell therapies
Miwa, H., Dimatteo, R., de Rutte, J. M., Ghosh, R., & Carlo, D. D. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00422-x · Cited by 55
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies
Rosati, J. D., Ferrari, D., Altieri, F., Tardivo, S., Ricciolini, C., Fusilli, C., Zalfa, C., Profico, D. C., Pinos, F., Bernardini, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0990-2 · Cited by 49
Wang, D., Li, S., Fu, J., Bai, L., & Guo, L. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.01.005 · Cited by 46
Williamson, M. R., Le, S. P., Franzen, R. L., Donlan, N. A., Rosow, J. L., Nicot-Cartsonis, M. S., Cervantes, A., Deneen, B., Dunn, A. K., Jones, T. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42138-0 · Cited by 54
Immunological properties of embryonic and adult stem cells
Bifari, F., Pacelli, L., & Krampera, M. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i3.50 · Cited by 54
Papale, A., d’Isa, R., Menna, E., Cerovic, M., Solari, N., Hardingham, N. R., Cambiaghi, M., Cursi, M., Barbacid, M., Leocani, L., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.016 · Cited by 50
Doeppner, T. R., Kaltwasser, B., Sánchez-Mendoza, E. H., Çağlayan, A. B., Bähr, M., & Hermann, D. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16647738 · Cited by 47
Self-citationStem Cell–Based Immunomodulation After Stroke: Effects on Brain Repair Processes
Boshuizen, M. C. S., & Steinberg, G. K. (2018) · Stroke · doi:10.1161/strokeaha.117.020465 · Cited by 50
“the survival of endogenous glial and neuronal progenitors after ischemia.(17,18,51) Decreases in cell death are often accom-”
BackgroundInfluentialXu, H., Zhang, J., Tsang, K. S., Yang, H., & Gao, W. (2019) · Stem Cells International · doi:10.1155/2019/5432301 · Cited by 50
“Currently, an increasing body of literature indicates that stem cells exert neuroprotective effects that are more likely attributed to their paracrine effects and anti-inflammatory responses [87, 88, 93, 94].”
BackgroundA possible new focus for stroke treatment – migrating stem cells
Sullivan, R., Duncan, K., Dailey, T., Kaneko, Y., Tajiri, N., & Borlongan, C. V. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1043264 · Cited by 49
“Although these factors and specific molecules proved to be effective in increasing the proliferation of endogenous stem cells, the overall number and survival rates of neurons produced from these proliferative cells were extremely low [42,55].”
BackgroundZinnhardt, B., Wiesmann, M., Honold, L., Barca, C., Schäfers, M. A., Kiliaan, A. J., & Jacobs, A. H. (2018) · Theranostics · doi:10.7150/thno.24128 · Cited by 50
“Observed effects include increased neurological plasticity [142] and stimulation of angiogenesis and, therefore, revascularization of the ischemic tissue [143–147].”
BackgroundMesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Doeppner, T. R., & Hermann, D. M. (2010) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s7820 · Cited by 44
“13,17 ,18–21 Application of mesenchymal stem cells (MSCs) has become an interesting tool in stroke research as they offer broad therapeutic strategies, including clinically relevant autologous transplantation of bone marrow (BM)-derived MSCs. 22 In this review, we first describe some fundamental…”
Self-citationChang, D.-J., Oh, S.-H., Lee, N., Choi, C., Jeon, I., Kim, H. S., Shin, D. A., Lee, S. E., Kim, D., & Song, J. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.93 · Cited by 45
Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment
Fernández‐Susavila, H., Bugallo-Casal, A., Castillo, J., & Campos, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00908 · Cited by 45
Hu, B., Chen, S., Zou, M., He, Z., Shao, S., & Liu, B. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452533 · Cited by 42
Radandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 43
Differentiating human stem cells into neurons and glial cells for neural repair
Selvaraj, V., Jiang, P., Chechneva, O., Lo, U., & Deng, W. (2011) · Frontiers in bioscience · doi:10.2741/3916 · Cited by 43
“In addition to replacement of lost neurons, neurotrophic factors secreted by transplanted cells can promote angiogenesis and enhance survival of damaged neurons (214, 215).”
BackgroundDoeppner, T. R., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00357 · Cited by 47
“…have been used for therapeutic purposes, which were transplanted either locally or systemically in experimental models of focal cerebral ischemia (Bacigaluppi et al., 2008, 2009; Schwarting et al., 2008; Bliss et al., 2010; Zheng et al., 2010; Banerjee et al., 2012; Doeppner et al., 2012; Leong…”
Self-citationHarnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology
Willis, C. M., Nicaise, A. M., Hamel, R., Pappa, V., Peruzzotti‐Jametti, L., & Pluchino, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590960 · Cited by 49
Zhang, Q., & Zhao, Y. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500049 · Cited by 40
Lahiani, A., Brand-Yavin, A., Yavin, E., & Lazarovici, P. (2018) · Brain Sciences · doi:10.3390/brainsci8020032 · Cited by 43
“In contrast, bone marrow, cord blood and placental stem cell and derived progenitors have been shown to be efficient in the therapy of many diseases of the CNS, including stroke [171].”
BackgroundVonderwalde, I., Azimi, A., Rolvink, G., Ahlfors, J.-E. W., Shoichet, M. S., & Morshead, C. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-0691-x · Cited by 43
Mahdavipour, M., Hassanzadeh, G., Seifali, E., Mortezaee, K., Aligholi, H., Shekari, F., Sarkoohi, P., Zeraatpisheh, Z., Nazari, A., Movassaghi, S., et al. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3484 · Cited by 44
“Administration of NSCs is reported to be effective for both subacute and chronic phase of stroke acting in a multi-faceted way including preservation of blood-brain barrier (BBB), alleviation of neuroinflammation, enhancement of regeneration, plasticity, and neurogenesis, and ultimately improvement of functional neuro…”
BackgroundZhang, S., Kong, D., Ma, G., Liu, C., Yang, Y., Liu, S., Jiang, N., Pan, Z., Zhang, W., Kong, L., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00844-9 · Cited by 46
Praet, J., Reekmans, K., Lin, D. Y., Vocht, N. D., Bergwerf, I., Tambuyzer, B. R., Daans, J., Hens, N., Goossens, H., Pauwels, P., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x636920 · Cited by 39
Fang, J., Zhang, S., Liu, Z., Pan, Y., Cao, L., Hou, P., Chen, Y., Zhang, Y., Li, X., Liu, R., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0447 · Cited by 44
Berlet, R., Cabantan, D. A. G., Gonzales-Portillo, D., & Borlongan, C. V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.798826 · Cited by 43
Ding, D., Lin, C.-H., Shyu, W., & Lin, S. (2013) · Cell Transplantation · doi:10.3727/096368912x655091 · Cited by 41
Doeppner, T. R., Kaltwasser, B., Fengyan, J., Hermann, D. M., & Bähr, M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.126 · Cited by 38
Self-citationShimada, I. S., & Spees, J. L. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22963 · Cited by 38
“…to treat models of stroke, including ES cells, iPS cells, neural stem/progenitor cells (NSC/NPC), and bone marrow-derived non-hematopoietic multipotent stromal cells (BMSC) [Chen et al., 2001; Haas et al., 2005; Bliss et al., 2007; Bacigaluppi et al., 2009; Hicks et al., 2009; Kawai et al., 2010].”
BackgroundThe potential of stem cell therapy for stroke: is PISCES the sign?
Smith, H. K., & Gavins, F. N. E. (2012) · The FASEB Journal · doi:10.1096/fj.11-195719 · Cited by 38
Doeppner, T. R., Traut, V., Heidenreich, A., Kaltwasser, B., Bosche, B., Bähr, M., & Hermann, D. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9748-y · Cited by 41
Self-citationEndothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
Gulati, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094959 · Cited by 39
Green, C., Minassian, A., Vogel, S. N., Diedenhofen, M., Beyrau, A., Wiedermann, D., & Hoehn, M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2715-17.2018 · Cited by 39
“Several experimental investigations have already reported outcome improvement after stem cell implantation in rodent models of stroke (Bacigaluppi et al., 2009; Minnerup et al., 2011; Doeppner et al., 2017).”
BackgroundThe effect of age, sex and strains on the performance and outcome in animal models of stroke
Zhang, H., Lin, S., Chen, X., Gu, L., Zhu, X., Zhang, Y., Reyes, K., Wang, B. Z., & Jin, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.005 · Cited by 40
CNS and peripheral immunity in cerebral ischemia: partition and interaction
Kim, E., & Cho, S. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113508 · Cited by 42
Human Neural Stem Cells for Cell-Based Medicinal Products
Fernández‐Muñoz, B., García-Delgado, A. B., Arribas-Arribas, B., & Sánchez‐Pernaute, R. (2021) · Cells · doi:10.3390/cells10092377 · Cited by 40
Boy, S., Sauerbruch, S., Kraemer, M., Schormann, T., Schlachetzki, F., Schuierer, G. R., Luerding, R., Hennemann, B., Orsó, E., Dabringhaus, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023099 · Cited by 37
“. Dirk Hermann and his group recently suggested multiple bystander effects of transplanted neuronal precursor cells, such as reduction of inflammation, glial scar formation, and neuronal apoptotic death contributing to functional recovery in mice”
BackgroundDeng, M., Xiao, H., Peng, H., Yuan, H., Xu, Y., Zhang, G., Tang, J., & Hu, Z. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13784 · Cited by 35
“It can also cause a downregulation of proinflammatory cytokines (Bacigaluppi et al., 2009).”
BackgroundMethodAboutaleb, N., Faezi, M., Maleki, S. N., Nazarinia, D., Tousi, S. M. T. R., & Hashemirad, N. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.02.003 · Cited by 36
Ottoboni, L., Feo, D. D., Merlini, A., & Martino, G. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.05.005 · Cited by 35
Self-citationLee, I., Huang, S., Chuang, C.-Y., Liao, K., Chang, L.-H., Chuang, C.-C., Su, Y.-S., Lin, H.-J., Hsieh, J.-Y., Su, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02137-w · Cited by 32
Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
Öz, T., Kaushik, A. K., & Kujawska, M. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i7.687 · Cited by 40
Doeppner, T. R., Kaltwasser, B., Teli, M. K., Sánchez-Mendoza, E. H., Kılıç, E., Bähr, M., & Hermann, D. M. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.023 · Cited by 35
Self-citationCurrent developments in cell- and biomaterial-based approaches for stroke repair
Jendelová, P., Kubinová, Š., Sandvig, I., Erceg, S., Sandvig, A., & Syková, E. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1094457 · Cited by 37
“NPCs can secrete many of these regulatory molecules [44], and are also able to beneficially modulate inflammatory responses after CNS damage [45,46].”
BackgroundTime limited immunomodulatory functions of transplanted neural precursor cells
Fainstein, N., Einstein, O., Cohen, M. E., Brill, L., Lavon, I., & Ben‐Hur, T. (2012) · Glia · doi:10.1002/glia.22420 · Cited by 33
“tive effects were observed following NPC transplantation in models of stroke and trauma, where the acute inflammatory process contributes to tissue injury and neurologic disability (Bacigaluppi et al., 2009).”
BackgroundNamestnikova, D. D., Gubskiy, I. L., Revkova, V. A., Sukhinich, K. K., Melnikov, P., Gabashvili, A. N., Cherkashova, E. A., Vishnevskiy, D. A., Kurilo, V. V., Burunova, V. V., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.641970 · Cited by 37
“In animal stroke models, transplanted allogeneic NPC most likely influenced brain neural, glial and immune cells and enhanced brain tissue protection and regeneration via secretion of cytokines, growth factors and other biologically active substances (Bacigaluppi et al., 2009; Baker et al., 2019; Vonderwalde et al., 2…”
BackgroundYao, H., Gao, M., Ma, J., Zhang, M., Li, S., Wu, B., Nie, X., Jiao, J., Zhao, H., Wang, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137211 · Cited by 31
“Neural stem cells (NSCs) promote recovery of neurological disease and show anti-inflammatory, glial scar-inhibitory, and anti-apoptotic effects with neuroprotective functions [1].”
BackgroundHuman iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications
Cefalo, M. G., Carai, A., Miele, E., Pò, A., Ferretti, E., Mastronuzzi, A., & Germano, I. M. (2015) · Stem Cells International · doi:10.1155/2016/4869071 · Cited by 35
“Modulation of immune and inflammatory response [57] is achieved by reducing the main inflammatory regulators in focal brain tissue, such as microglia, by inducing the downregulation of some inflammatory regulators, such as TNF-alpha, IL-6, and leptin receptors.”
Capobianco, D. L., Zio, R. D., Profico, D. C., Gelati, M., Simone, L., D’Erchia, A. M., Palma, F. D., Mormone, E., Bernardi, P., Sbarbati, A., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07005-w · Cited by 34
“Notably, human NSCs (hNSCs) have exhibited neuroprotective effects in murine models, rescuing neurons from ischemia-induced apoptosis without differentiating into neurons [15].”
BackgroundImplanted Neurosphere-Derived Precursors Promote Recovery After Neonatal Excitotoxic Brain Injury
Titomanlio, L., Bouslama, M., Verche, V. L., Dalous, J., Kaindl, A. M., Tsenkina, Y., Lacaud, A., Peineau, S., Ghouzzi, V. E., Lelièvre, V., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0302 · Cited by 33
“Various protective and = or regenerative mechanisms by which NSCs could exert their effects have been described, and several of these could be involved in our model [49–53].”
Moniche, F., Rosado-de-Castro, P. H., Escudero‐Martínez, I., Zapata‐Arriaza, E., Laviana, F. J. D. L. T., Méndez‐Otero, R., Carmona, M., Piñero, P., Bustamante, A., Lebrato, L., et al. (2016) · Stem Cells International · doi:10.1155/2016/8657173 · Cited by 33
Novel Therapeutic Transplantation of Induced Neural Stem Cells for Stroke
Yamashita, T., Liu, W., Matsumura, Y., Miyagi, R., Zhai, Y., Kusaki, M., Hishikawa, N., Ohta, Y., Kim, S. M., Kwak, T. H., et al. (2016) · Cell Transplantation · doi:10.3727/096368916x692988 · Cited by 30
Oligodendrogenesis after traumatic brain injury
Takase, H., Washida, K., Hayakawa, K., Arai, K., Wang, X., Lo, E. H., & Lok, J. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.042 · Cited by 32
SSEA4-Positive Pig Induced Pluripotent Stem Cells are Primed for Differentiation into Neural Cells
Yang, J., Mumaw, J. L., Liu, Y., Stice, S. L., & West, F. D. (2013) · Cell Transplantation · doi:10.3727/096368912x657279 · Cited by 33
“For example, transplant of human and mouse pluripotent stem cells, NPs, and early neurons and glia have all resulted in significant improvement in animal models for multiple sclerosis, stroke, and spinal cord injury (1,3,8,10,46).”
BackgroundHatakeyama, M., Ninomiya, I., Otsu, Y., Omae, K., Kimura, Y., Onodera, O., Fukushima, M., Shimohata, T., & Kanazawa, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176194 · Cited by 32
Neuroprotection of Stem Cells Against Ischemic Brain Injury: From Bench to Clinic
Liu, X., & Jia, X. (2023) · Translational Stroke Research · doi:10.1007/s12975-023-01163-3 · Cited by 32
“Grafted NSCs played a neuroprotective role by reducing inflammation, leading to reduced infarct volume and better neurological performance [110, 111].”
Li, Y., Yu, J., Xi, J.-Y., Yu, W., Liu, J., Wang, Q., Song, L.-J., Feng, L., Yan, Y., Zhang, G., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0027-8 · Cited by 30
Volpe, G., Bernstock, J. D., Peruzzotti-Jametti, L., & Pluchino, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.005 · Cited by 28
“…talk with other components of the atypical niche, including endothelial cells, blood-born inflammatory cells, activated macrophages and microglia, and/or reactive astrocytes (Bacigaluppi et al., 2009, Cossetti et al., 2012, Cusimano et al., 2012, Pluchino and Cossetti, 2013, Sun et al., 2010).”
BackgroundDoeppner, T. R., Bähr, M., Giebel, B., & Hermann, D. M. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418789326 · Cited by 29
Self-citationNazarinia, D., Aboutaleb, N., Gholamzadeh, R., Maleki, S. N., Mokhtari, B., & Nikougoftar, M. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.101707 · Cited by 28
Noh, J.-E., Oh, S.-H., Park, I.-H., & Song, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.546659 · Cited by 28
“To quantify GFAP+ glial scarring (Bacigaluppi et al., 2009), GFAP+ areas in two representative ROIs of the peri-infarct cortex and striatum were measured at 20× magnification.”
BackgroundMethodInfluentialRepair of the CNS Using Endogenous and Transplanted Neural Stem Cells
Trueman, R. C., Klein, A., Lindgren, H. S., Lelos, M. J., & Dunnett, S. B. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_223 · Cited by 30
“Bacigaluppi et al. (2009) report functional recovery with this cell source following systemic administration in a model of focal ischaemia.”
BackgroundExtracellular matrices, artificial neural scaffolds and the promise of neural regeneration
Grandhi, R., Ricks, C., Shin, S., & Becker, C. J. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.141778 · Cited by 36
“…the damaged or degenerative cell types (Zhu et al., 2009), but also by secreting various neurotropic factors like nerve growth facture and brain-derived neurotrophic factor (BDNF) (Lu et al., 2003), and by inhibiting T cell activation, thus preventing further injury (Bacigaluppi et al., 2009).”
BackgroundOh, S., Jeong, Y.-W., Choi, W., Noh, J., Lee, S., Kim, H. S., & Song, J. (2020) · Stem Cells International · doi:10.1155/2020/4061516 · Cited by 30
“Several studies have demonstrated that transplantation of NPCs decreases the numbers of Iba-1- and/or ED1-positive microglia [11, 20, 33] and the expression of proinflammatory cytokines [43, 52].”
BackgroundOptimization of time for neural stem cells transplantation for brain stroke in rats
Ziaee, S. M., Tabeshmehr, P., Haider, K. H., Farrokhi, M. R., Shariat, A., Amiri, A., & Hosseini, S. M. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.03.10 · Cited by 27
Brain Region-Dependent Rejection of Neural Precursor Cell Transplants
Fainstein, N., & Ben‐Hur, T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00136 · Cited by 41
“While these properties proved to be clinically significant in inhibiting neuroinflammation (Einstein et al., 2006b; Bacigaluppi et al., 2009; Pluchino et al., 2009a), the eventual loss of these properties after NPC transplantation into the naïve brain, resulted in their active rejection (Fainstein et al.”
BackgroundNeurovascular remodeling in the aged ischemic brain
Hermann, D. M., Buga, A.-M., & Popa‐Wagner, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1148-0 · Cited by 30
“Most NPCs in the vicinity of a stroke lesion exhibit an undifferentiated immunohistochemical phenotype, lacking mature neuronal markers such as NeuN (Bacigaluppi et al. 2009; Doeppner et al. 2012).”
BackgroundSelf-citationTherapeutic stem cell plasticity orchestrates tissue plasticity
Martino, G., Bacigaluppi, M., & Peruzzotti‐Jametti, L. (2011) · Brain · doi:10.1093/brain/awr115 · Cited by 27
“…neural progenitor cells to protect the CNS from diverse injuries using multifaceted 'bystander' effects— the concept of therapeutic plasticity (Martino and Pluchino, 2006)—has already been substantiated in several experimental neurological diseases, including stroke (Bacigaluppi et al., 2009).”
BackgroundSelf-citationThe Role of Stem Cells in the Therapy of Stroke
Brzecka, A., Ejma, M., Madetko‐Alster, N., Alster, P., Budrewicz, S. P., Koszewicz, M. A., Misiuk‐Hojło, M., Константиновна, Т. И., Somasundaram, S. G., & Kirkland, C. E. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210806163352 · Cited by 30
“During the first 72 hours after intravenous administration, SC were found in both brain hemispheres [98].”
Qin, J., Gong, G., Shilei, S., Qi, J., Zhang, H., Wang, Y., Wang, N., Wang, Q. M., Ji, Y., Gao, Y., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.047 · Cited by 28
Pluchino, S., Cusimano, M. D., Bacigaluppi, M., & Martino, G. (2010) · PubMed · Cited by 27
Self-citationTajiri, N., Lee, J.-Y., Acosta, S., Sanberg, P. R., & Borlongan, C. V. (2016) · Cell Transplantation · doi:10.3727/096368916x690971 · Cited by 25
Imai, R., Tamura, R., Yo, M., Sato, M., Fukumura, M., Takahara, K., Kase, Y., Okano, H., & Toda, M. (2023) · Stem Cells · doi:10.1093/stmcls/sxad028 · Cited by 31
Metadata
- Authors
- Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, Ü., Salani, G., Brambilla, E., West, M. J., Comi, G., Martino, G., & Hermann, D. M.
- Affiliations
- University Hospital Zurich (CH)
- IRCCS Ospedale San Raffaele (IT)
- Aarhus University (DK)
- Corresponding author
- Hermann, Dirk M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-16
- Volume
- 132
- Issue
- 8
- Pages
- 2239-2251
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117381245
- Cited by
- 350
- References
- 59
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 26 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 29 · 2015: 27 · 2014: 33 · 2013: 29 · 2012: 32
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (112056, 3200B0)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neural stem cell transplantation, ischemic stroke, middle cerebral artery occlusion, bystander effect, neuronal apoptosis, glial scar formation, neuroinflammation, delayed neuronal death, neurological recovery, gene expression
- MeSH terms
- Animals, Astrocytes, Atrophy, Brain, Cell Survival, Cicatrix, Corpus Callosum, Disease Models, Animal, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Neurons, Disease Progression, Stroke, Gene Expression Profiling, Stem Cell Transplantation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.